Anticipate That Brexanolone Will Be Saved for Severe Postpartum Depression

Brexanolone (Zulresso, zul-REH-soh) will be a new injectable med for treating postpartum depression.

Women with postpartum depression often get SSRIs (sertraline, etc)...which take a week or more to start working. Brexanolone's effects kick in sooner...within 24 to 48 hours.

But expect brexanolone to be saved for severe cases. It costs up to $34,000/course...and it can cause serious side effects, such as sedation and loss of consciousness.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals